These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 18299784)

  • 1. [Positive and negative social representation of ecstasy among consumers in Coimbra (Portugal)].
    Mendes FJ; Lomba L
    Adicciones; 2008; 20(1):81-8. PubMed ID: 18299784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Young adults' recreational social environment as a predictor of ecstasy use initiation: findings of a population-based prospective study.
    Smirnov A; Najman JM; Hayatbakhsh R; Wells H; Legosz M; Kemp R
    Addiction; 2013 Oct; 108(10):1809-17. PubMed ID: 23668641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in-depth qualitative examination of the ecstasy experience: results of a focus group with ecstasy-using college students.
    Levy KB; O'Grady KE; Wish ED; Arria AM
    Subst Use Misuse; 2005; 40(9-10):1427-41. PubMed ID: 16048826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alcohol use and risk taking among regular ecstasy users.
    Breen C; Degenhardt L; Kinner S; Bruno R; Jenkinson R; Matthews A; Newman J
    Subst Use Misuse; 2006; 41(8):1095-109. PubMed ID: 16798678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ecstasy (MDMA): effects and patterns of use reported by users in São Paulo.
    de Almeida SP; Silva MT
    Braz J Psychiatry; 2003 Mar; 25(1):11-7. PubMed ID: 12975674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome expectancies and ecstasy use in visitors of rave parties in The Netherlands.
    Engels RC; ter Bogt T
    Eur Addict Res; 2004; 10(4):156-62. PubMed ID: 15367816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns and harms of pharmaceutical drug use among ecstasy users in Australia.
    Silins E; Copeland J; Dillon P
    Adicciones; 2009; 21(4):347-62. PubMed ID: 20011991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mind Zone--prevention in the techno-scene].
    Nitschke S
    Gesundheitswesen; 1998 Aug; 60 Suppl 1():S56-8. PubMed ID: 9816762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An investigation of factors associated with depressive symptoms among a sample of regular ecstasy consumers.
    Matthews AJ; Bruno R
    Neuropsychobiology; 2010; 61(4):215-22. PubMed ID: 20389132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dancing hot on Ecstasy: physical activity and thermal comfort ratings are associated with the memory and other psychobiological problems reported by recreational MDMA users.
    Parrott AC; Rodgers J; Buchanan T; Ling J; Heffernan T; Scholey AB
    Hum Psychopharmacol; 2006 Jul; 21(5):285-98. PubMed ID: 16856221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users.
    Schilt T; de Win MM; Jager G; Koeter MW; Ramsey NF; Schmand B; van den Brink W
    Psychol Med; 2008 Sep; 38(9):1309-17. PubMed ID: 17988417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rave drugs: pharmacological considerations.
    Klein M; Kramer F
    AANA J; 2004 Feb; 72(1):61-7. PubMed ID: 15098519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-year trends in patterns of drug use among people who use stimulants in dance contexts in the United Kingdom.
    McCambridge J; Mitcheson L; Winstock A; Hunt N
    Addiction; 2005 Aug; 100(8):1140-9. PubMed ID: 16042644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging psychoactive substance use among regular ecstasy users in Australia.
    Bruno R; Matthews AJ; Dunn M; Alati R; McIlwraith F; Hickey S; Burns L; Sindicich N
    Drug Alcohol Depend; 2012 Jul; 124(1-2):19-25. PubMed ID: 22209387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pediatric forum: ecstasy use among club rave attendees.
    Arria AM; Yacoubian GS; Fost E; Wish ED
    Arch Pediatr Adolesc Med; 2002 Mar; 156(3):295-6. PubMed ID: 11876678
    [No Abstract]   [Full Text] [Related]  

  • 16. Negative experiences on Ecstasy: the role of drug, set and setting.
    McElrath K; McEvoy K
    J Psychoactive Drugs; 2002; 34(2):199-208. PubMed ID: 12691210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Getting into ecstasy: comparing moderate and heavy young adult users.
    Sterk CE; Theall KP; Elifson KW
    J Psychoactive Drugs; 2007 Jun; 39(2):103-13. PubMed ID: 17703705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward an ecstasy and other club drug (EOCD) prevention intervention for rave attendees.
    Yacoubian GS; Miller S; Pianim S; Kunz M; Orrick E; Link T; Palacios WR; Peters RJ
    J Drug Educ; 2004; 34(1):41-59. PubMed ID: 15468747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to find future ecstasy-users: targeted and snowball sampling in an ethically sensitive context.
    Vervaeke HK; Korf DJ; Benschop A; van den Brink W
    Addict Behav; 2007 Aug; 32(8):1705-13. PubMed ID: 17188817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex, touch, and HIV risk among ecstasy users.
    Theall KP; Elifson KW; Sterk CE
    AIDS Behav; 2006 Mar; 10(2):169-78. PubMed ID: 16456728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.